对于活激素聚合的高度通用的器官胺介质
Shigeru Yamago1, Biswajit Ray, Kazunori Iida
1Division of Molecular Material Science, Graduate School of Science, Osaka City University and PREST, Japan Science and Technology Corporation, Osaka 558-8585, Japan. yamago@sci.osaka-cu.ac.jp
Journal of the American Chemical Society
|October 28, 2004
概括
一种新的有机胺介导方法使各种单体的活基聚合成为可能. 这种技术实现了受控的聚合物合成,并为先进的纳米材料创建了独特的块共聚合物.
科学领域:
- 聚合物化学 聚合物化学
- 有机合成 有机合成
- 材料科学 材料科学 材料科学
背景情况:
- 活基聚合 (LRP) 对于合成具有受控架构的聚合物至关重要.
- 现有的LRP方法在单体范围和效率方面存在局限性.
- 开发多功能LRP技术对于先进的聚合物材料至关重要.
研究的目的:
- 引入一种新的,多功能方法,用于活激素聚合.
- 为了证明结合和未结合的乙烯基单体的受控聚合.
- 从结合和未结合的单体合成新型块共聚物.
主要方法:
- 机体素被用来诱导与基因连续发生的集团转移激进反应.
- 该方法应用于一系列的乙烯基单体,包括结合和未结合的类型.
- 监测了聚合反应,以确保对分子量和多分散性的控制.
主要成果:
- 结合和未结合的乙烯基单体的成功控制聚合得到了实现.
- 具有预先确定的分子量和低多分散度指数的聚合物得到了很好的产量.
- 完成了由结合和未结合的单体组成的第一个块共聚合物的合成.
结论:
- 开发的有机胺介导方法为活基聚合提供了一种多功能和高效的方法.
- 这种技术提供了对聚合物合成的精确控制,使得生产精确定义的聚合物成为可能.
- 创造新型块共聚合物的能力为开发功能性智能有机纳米材料开辟了道路.
相关概念视频
Intracellular Hormone Receptors
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Therapeutic Classification
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...


![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)